InsidersTradesSigma
Discover the detailed record of transactions filed by Pahl, Prof. Dr. Andreas, Management Board. Insider active across 1 companies, notably Heidelberg Pharma AG. Aggregated, 1 reports have been recorded. The latest transaction was filed on 23 July 2025 — Other. Regulator: BaFin. The full history is accessible without signup.
1 of 1 declaration
Prof. Dr. Andreas Pahl is a member of the Management Board at Heidelberg Pharma AG. He brings valuable expertise in the field of pharmaceutical research and development. His role involves overseeing strategic operations and guiding the scientific direction of the company.